MiMedx Group Inc reports results for the quarter ended in December - Earnings Summary

MiMedx

28/02/2024 23:17

* MiMedx Group Inc  MDXG.OQ  reported quarterly adjusted
earnings
of 32 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -2 cents.  The mean expectation of five analysts
for the quarter was for earnings of 7 cents per share. Wall
Street expected results to range from 6 cents to 8 cents per
share.
    * Revenue rose 16.7% to $86.83 million from a year ago;
analysts
expected $85.05 million. 
    * MiMedx Group Inc's reported EPS for the quarter was 32
cents​.
    * The company reported quarterly net income of $44.83
million.
    * MiMedx Group Inc shares had fallen by 4.2% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MiMedx Group Inc
is $12.00 
This summary was machine generated from LSEG data February 28 at
11:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.07           0.32           Beat
 Sep. 30 2023      0.05           0.06           Beat
 Jun. 30 2023      -0.02          0.00           Beat
 Mar. 31 2023      -0.09          -0.06          Beat